Motivational O
Deficits O
in O
Schizophrenia O
Are O
Associated O
with O
Reduced O
Differentiation O
between O
Gain O
and O
Loss-Avoidance O
Feedback O
in O
the O
Striatum O
Background O
The O
current O
study O
was O
designed O
to O
test O
the O
hypothesis O
that O
motivational O
deficits O
in O
schizophrenia O
( O
SZ O
) O
are O
tied O
to O
a O
reduced O
ability O
to O
differentially O
signal O
gains O
and O
instances O
of O
loss-avoidance O
in O
the O
brain O
, O
leading O
to O
reduced O
ability O
to O
form O
adaptive O
representations O
of O
expected O
value O
. O

Methods O
We O
administered O
a O
reinforcement O
learning O
paradigm O
to O
27 O
medicated O
SZ O
patients O
and O
27 O
controls O
, O
in O
which O
participants O
learned O
three O
probabilistic O
discriminations O
. O

In O
regions O
of O
interest O
in O
reward O
networks O
identified O
a O
priori O
, O
we O
examined O
contrasts O
between O
trial-types O
with O
different O
expected O
values O
( O
Expected O
Gain O
– O
Non-monetary O
, O
e.g O
. O

) O
, O
and O
between O
outcomes O
with O
the O
same O
prediction O
error O
valence O
but O
different O
experienced O
values O
( O
Gain O
– O
Loss-avoidance O
outcome O
, O
Miss O
– O
Loss O
outcome O
, O
e.g O
. O
) O
. O

Results O
Both O
whole-brain O
and O
regions-of-interest O
analyses O
revealed O
that O
schizophrenia O
patients O
showed O
reduced O
differentiation O
between O
Gain O
and O
Loss-avoidance O
outcomes O
in O
dorsal O
anterior O
cingulate O
cortex O
and O
bilateral O
anterior O
insula O
. O

That O
is O
, O
SZ O
patients O
showed O
reduced O
contrasts O
between O
positive O
prediction O
errors O
of O
different O
objective O
values O
in O
these O
areas O
. O

Furthermore O
, O
we O
observed O
significant O
correlations O
between O
[ O
Gain O
– O
Loss-avoidance O
outcome O
] O
contrasts O
in O
ventral O
striatum O
and O
ratings O
for O
Avolition/Anhedonia O
, O
and O
between O
[ O
Expected O
Gain O
– O
Non-monetary O
] O
contrasts O
in O
ventral O
striatum O
and O
ventromedial O
prefrontal O
cortex O
. O

Conclusions O
These O
results O
provide O
further O
evidence O
for O
intact O
prediction O
error O
signaling O
in O
medicated O
schizophrenia O
patients O
, O
especially O
with O
regard O
to O
loss-avoidance O
. O

By O
contrast O
components O
of O
frontostriatal O
circuits O
appear O
to O
show O
reduced O
sensitivity O
to O
the O
absolute O
valence O
of O
expected O
and O
experienced O
outcomes O
, O
suggesting O
a O
mechanism O
by O
which O
motivational O
deficits O
may O
emerge O
. O

Methods O
and O
Materials O
General O
Procedures O
Twenty-nine O
SZ O
patients O
and O
28 O
healthy O
volunteers O
, O
matched O
on O
demographic O
characteristics O
and O
smoking O
status O
, O
successfully O
completed O
an O
RL O
task O
in O
the O
MRI O
scanner O
( O
see O
Supplementary O
Methods O
for O
details O
of O
screening O
procedures O
) O
. O

All O
patients O
except O
one O
were O
medicated O
with O
antipsychotic O
drugs O
, O
with O
all O
those O
medicated O
being O
on O
stable O
antipsychotic O
medication O
regimens O
( O
no O
changes O
for O
four O
weeks O
) O
. O

Outside O
of O
the O
MRI O
scanner O
, O
cognitive O
function O
was O
assessed O
using O
three O
standard O
measures O
: O
the O
Wechsler O
Abbreviated O
Scale O
of O
Intelligence O
( O
WASI O
; O
23 O
) O
, O
the O
Wechsler O
Test O
of O
Adult O
Reading O
( O
WTAR O
; O
24 O
) O
, O
and O
the O
MATRICS O
battery O
. O

Standard O
symptom O
ratings O
were O
obtained O
for O
all O
patients O
using O
the O
Scale O
for O
the O
Assessment O
of O
Negative O
Symptoms O
( O
SANS O
; O
26 O
) O
, O
the O
Brief O
Psychiatric O
Rating O
Scale O
( O
BPRS O
; O
27 O
) O
, O
and O
the O
Calgary O
Depression O
Scale O
( O
CDS O
; O
28 O
) O
. O

Acquisition O
of O
behavioral O
and O
neuroimaging O
data O
Participants O
performed O
240 O
trials O
( O
average O
length O
: O
6 O
s O
) O
of O
a O
version O
of O
the O
Gain O
vs. O
Loss-avoidance O
probabilistic O
RL O
task O
similar O
to O
that O
used O
in O
our O
prior O
work O
( O
19 O
; O
Table O
1 O
) O
. O

Functional O
MRI O
data O
were O
acquired O
simultaneous O
with O
task O
performance O
, O
in O
four O
EPI O
scanning O
runs O
, O
each O
lasting O
≈7 O
minutes O
( O
with O
lead O
time O
) O
and O
involving O
the O
acquisition O
of O
191 O
whole-brain O
functional O
EPI O
images O
( O
for O
measurement O
of O
T2 O
* O
-weighted O
BOLD O
effects O
) O
using O
a O
3-T O
Siemens O
Trio O
scanner O
( O
Erlangen O
, O
Germany O
; O
81 O
2-mm O
axial O
slices O
; O
128 O
× O
128 O
matrix O
; O
FOV O
= O
22 O
× O
22 O
cm O
; O
TR O
= O
2 O
s O
; O
see O
Supplementary O
Methods O
for O
additional O
scanning O
parameters O
) O
. O

Also O
, O
in O
each O
session O
, O
we O
acquired O
a O
whole-brain O
T1-weighted O
structural O
image O
( O
MPRAGE O
) O
for O
anatomical O
reference O
( O
1-mm3 O
isotropic O
voxels O
) O
. O

Two O
patients O
were O
removed O
from O
subsequent O
analyses O
due O
to O
head O
motion O
sufficient O
to O
produce O
phase-instability O
in O
the O
functional O
images O
( O
resulting O
in O
the O
loss O
of O
entire O
runs O
to O
artifact O
) O
. O

One O
control O
was O
excluded O
from O
subsequent O
analyses O
, O
due O
to O
a O
lack O
of O
task-engagement O
( O
evidenced O
by O
random O
button-pressing O
and O
no O
attempt O
to O
learn O
) O
. O

Analysis O
of O
Behavioral O
and O
Characterizing O
Data O
Groups O
did O
not O
differ O
in O
age O
, O
gender O
, O
race O
, O
and O
parental O
education O
( O
Table O
1 O
) O
. O

As O
expected O
, O
significant O
between-group O
differences O
were O
observed O
for O
participant O
educational O
attainment O
and O
multiple O
measures O
of O
overall O
intellectual O
functioning O
. O

Behavioral O
data O
were O
analyzed O
for O
the O
proportion O
of O
trials O
on O
which O
participants O
chose O
the O
optimal O
( O
more-frequently-reinforced O
) O
stimulus O
from O
a O
pair O
, O
as O
well O
as O
“ O
win-stay O
” O
and O
“ O
lose-shift O
” O
rates O
( O
see O
Supplementary O
Methods O
for O
details O
) O
. O

Finally O
, O
we O
used O
a O
computational O
model O
, O
similar O
to O
those O
previously O
used O
by O
our O
group O
, O
in O
order O
to O
estimate O
action O
values O
and O
prediction O
errors O
on O
a O
trial-wise O
basis O
. O

Comparison O
of O
multiple O
models O
revealed O
that O
a O
Q-learning O
model O
with O
separate O
learning O
rates O
for O
positive O
and O
negative O
RPEs O
fit O
the O
behavioral O
data O
the O
best O
( O
see O
Supplementary O
Materials O
for O
details O
) O
. O

Analyses O
of O
Event-related O
fMRI O
Data O
Single-subject O
Analyses O
We O
performed O
two O
sets O
of O
regression O
analyses O
( O
general O
linear O
models O
, O
or O
GLMs O
) O
of O
single-subject O
voxel-wise O
time O
series O
, O
one O
with O
binary O
regressors O
corresponding O
to O
the O
six O
different O
trial O
types O
( O
three O
different O
pairs O
x O
two O
possible O
outcomes O
) O
, O
and O
one O
using O
parametric O
regressors O
( O
see O
Supplementary O
Methods O
for O
details O
) O
. O

Binary O
regressors O
were O
3-second O
boxcar O
functions O
, O
time-locked O
to O
the O
onset O
of O
individual O
trials O
and O
convolved O
with O
a O
model O
hemodynamic O
response O
function O
. O

Parametric O
regressors O
were O
derived O
from O
the O
results O
of O
computational O
modeling O
of O
individual O
behavior O
, O
which O
allowed O
for O
the O
estimation O
of O
prediction O
errors O
on O
a O
trial-wise O
basis O
. O

Whole-brain O
Group-level O
Analyses O
To O
test O
for O
significant O
activations O
within O
groups O
, O
as O
well O
as O
for O
significant O
between-group O
differences O
in O
BOLD O
signal O
activations O
associated O
with O
parametric O
RPE O
regressors O
, O
we O
used O
whole-brain O
t-tests O
( O
AFNI O
3dttest++ O
command O
) O
. O

To O
test O
for O
significant O
within-group O
effects O
of O
outcome O
valence O
, O
we O
used O
whole-brain O
paired O
t-tests O
( O
AFNI O
3dttest++ O
command O
) O
. O

To O
test O
for O
significant O
between-group O
differences O
in O
BOLD O
signal O
contrasts O
with O
regard O
to O
experienced O
value O
and O
expected O
value O
, O
we O
used O
whole-brain O
multivariate O
models O
( O
AFNI O
3dMVM O
command O
) O
, O
with O
factors O
of O
group O
and O
value O
( O
6 O
levels O
of O
experienced O
value O
, O
3 O
levels O
of O
expected O
value O
) O
. O

For O
whole-brain O
analyses O
, O
we O
used O
a O
voxel-wise O
threshold O
of O
p=0.001 O
and O
a O
cluster-size O
threshold O
of O
95 O
voxels O
, O
determined O
by O
Monte O
Carlo O
simulations O
. O

Analyses O
of O
event-related O
neural O
responses O
in O
regions-of-interest O
( O
ROIs O
) O
Based O
on O
the O
prior O
literature O
, O
we O
looked O
for O
effects O
of O
expected O
value O
valence O
, O
RPE O
valence O
, O
and O
outcome O
valence O
in O
VS O
( O
bilaterally O
) O
, O
vmPFC/mOFC O
, O
dorsal O
anterior O
cingulate O
cortex O
( O
dACC O
) O
, O
right O
anterior O
insula O
( O
R O
AI O
) O
, O
and O
left O
anterior O
insula O
( O
L O
AI O
; O
see O
Figure O
2A–C O
for O
specific O
coordinates O
of O
ROIs O
; O
see O
Supplementary O
Materials O
for O
justification O
of O
coordinates O
chosen O
) O
. O

For O
the O
VS O
, O
we O
centered O
spheres O
of O
5-mm O
radius O
on O
( O
±10 O
, O
8 O
, O
−4 O
) O
to O
form O
a O
single O
, O
bilateral O
ROI O
. O

All O
ROIs O
in O
PFC O
consisted O
of O
spheres O
of O
10-mm O
radius O
. O

Our O
primary O
focus O
was O
on O
contrasts O
between O
outcomes O
of O
different O
objective O
values O
for O
the O
same O
RPE O
valence O
( O
e.g. O
, O
Gain O
vs. O
Loss-avoidance O
, O
Miss O
vs. O
Loss O
) O
. O

Exploratory O
analyses O
examined O
contrasts O
between O
expected O
outcomes O
, O
corresponding O
to O
condition O
( O
e.g. O
, O
Gain/Miss O
vs. O
Loss/Loss-avoidance O
) O
. O

For O
each O
of O
these O
contrasts O
, O
we O
performed O
the O
following O
tests O
: O
1 O
) O
a O
repeated-measures O
ANOVA O
, O
within O
the O
control O
group O
, O
with O
ROI O
as O
a O
factor O
, O
in O
order O
to O
determine O
if O
the O
contrast O
differed O
from O
zero O
in O
the O
control O
group O
, O
without O
respect O
to O
ROI O
, O
and O
if O
the O
contrast O
differed O
as O
a O
function O
of O
ROI O
; O
2 O
) O
a O
repeated-measures O
ANOVA O
, O
across O
the O
entire O
sample O
, O
with O
group O
and O
ROI O
as O
factors O
, O
in O
order O
to O
determine O
if O
there O
was O
a O
between-group O
difference O
in O
the O
contrast O
, O
without O
respect O
to O
ROI O
, O
or O
a O
significant O
group O
x O
ROI O
interaction O
; O
3 O
) O
Spearman O
correlation O
analyses O
, O
between O
MRI O
contrasts O
in O
ROIs O
and O
RL O
performance O
measures O
in O
controls O
; O
and O
4 O
) O
Spearman O
correlation O
analyses O
, O
between O
MRI O
contrasts O
in O
ROIs O
and O
measures O
of O
motivational O
deficits O
in O
patients O
. O

In O
order O
to O
quantify O
motivational O
deficits O
in O
patients O
, O
we O
computed O
an O
avolition/anhedonia O
factor O
score O
by O
averaging O
item O
scores O
from O
the O
avolition/role-functioning O
and O
anhedonia/asociality O
subscales O
of O
the O
SANS O
. O

In O
order O
to O
determine O
whether O
measures O
of O
motivational O
deficits O
in O
patients O
were O
related O
specifically O
to O
negative O
symptoms O
, O
rather O
than O
measures O
in O
multiple O
symptom O
classes O
, O
as O
well O
as O
cognitive O
domains O
, O
we O
also O
performed O
Spearman O
correlation O
analyses O
, O
between O
MRI O
contrasts O
in O
ROIs O
and O
1 O
) O
individual O
psychosis O
scores O
, O
by O
averaging O
ratings O
from O
individual O
psychosis O
items O
on O
the O
BPRS O
( O
Suspiciousness O
, O
Grandiosity O
, O
Hallucinations O
, O
and O
Unusual O
Thought O
Content O
) O
, O
2 O
) O
individual O
IQ O
estimates O
, O
as O
well O
as O
several O
measures O
of O
intellectual O
function O
from O
the O
MATRICS O
battery O
, O
and O
3 O
) O
standardized O
APD O
doses O
for O
SZ O
patients O
( O
see O
Supplementary O
Materials O
for O
conversions O
and O
results O
of O
correlation O
analyses O
) O
. O

